Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study

Reporting of Noninferiority and Equivalence Randomized Trials

(2013) Gilda Piaggio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class

(2011) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Generic and therapeutic substitutions in the UK: are they a good thing?

(2010) Martin G. Duerden et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Better compliance to antihypertensive medications reduces cardiovascular risk

(2010) Giovanni Corrao et al.   JOURNAL OF HYPERTENSION

Patients’ Perceptions Of Generic Medications

(2009) William H. Shrank et al.   HEALTH AFFAIRS

Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease

(2009) Barry L. Carter   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004?

(2008) Helle Håkonsen et al.   HEALTH POLICY

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in generic prescribing and dispensing in Europe

(2008) Steven Simoens   Expert Review of Clinical Pharmacology